All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
Inlyta 5mg Tablet_100871 (1)
Inlyta 5mg Tablet_100871 (2)
Inlyta 5mg Tablet_100871 (1)
18% Off

Inlyta 5mg Tablet

Prescription Required

Salt Composition : Axitinib

Manufacturer : PFIZER LTD

Origin of Medicine : United States of America

MRP: 41437
Price :33978
You Save :7459 (18%)

14 Tablet(s) In A Strip

PAP Information :    Buy 2, Get 4 Free. Contact us for latest updates.

Pincode
Delivery By -

Patient Assistance Programs
Know About PAP

Program Overview: PFIZER LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of inlyta 5mg Tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 2 strips of inlyta 5mg tablet, and you will receive 1 free strip. Therefore, if eligible, you will have to pay only Rs.65760 for 3 strips, which is Rs.21,920 per strip.

With MrMed's MRP discount of Rs.8857 per strip and Pfizer's PAP program, the overall savings is over 59 thousand rupees per purchase. 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the inlyta Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for axitinib 5mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by pfizer can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: PFIZER LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of inlyta 5mg Tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 2 strips of inlyta 5mg tablet, and you will receive 1 free strip. Therefore, if eligible, you will have to pay only Rs.65760 for 3 strips, which is Rs.21,920 per strip.

With MrMed's MRP discount of Rs.8857 per strip and Pfizer's PAP program, the overall savings is over 59 thousand rupees per purchase. 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the inlyta Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for axitinib 5mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by pfizer can avail of it without having to purchase the medication from MrMed.

Introduction to Inlyta 5mg Tablet

Inylta 5mg, containing the active ingredient Axitinib, is a tyrosine kinase inhibitor used to deal with advanced kidney cancer (renal cell carcinoma).

 

This drug can harm a fetus, so inform your doctor if you are pregnant or planning to conceive. Both men and women should use birth control during treatment and for one week after the last dose. Do not breastfeed during treatment, as it may affect the baby's development.
 

It is not advisable for use in children and adolescents under 18 years old. Urgently contact your healthcare provider if you develop symptoms like arrhythmia, chest pain, or a persistent cough. Your doctor may require regular monitoring of your white blood cells, platelets, blood sugar, electrolytes, and kidney function to avert complications. Additionally, report any digestive symptoms such as diarrhea, nausea, vomiting, or constipation to your healthcare provider without delay.


Uses of Inlyta 5mg Tablet

  • Targets specific enzymes to prevent the growth and spread of cancer cells.
  • Aids in reducing symptoms associated with advanced kidney cancer, improving the patient's quality of life.

Therapeutic Effects of Inlyta 5mg Tablet

Inlyta is a tyrosine kinase inhibitor. It disrupts the growth of blood vessels within cancer cells and targets receptor tyrosine kinases, a type of protein crucial for cell signaling. By interfering with these pathways, it effectively halts the proliferation and spread of cancer cells, contributing to the containment of the disease


Interaction of Inlyta 5mg Tablet with other drugs

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Inylta 5mg tablet and reduce effectiveness by causing undesirable side effects.


More Information about Inlyta 5mg Tablet

  • Keep Inlyta 5mg tablets in their original packaging and store them at room temperature, ideally between 20°C and 25°C.
  • Ensure the medication is kept out of the reach of children at all times.

How to consume Inlyta 5mg Tablet

Your doctor will decide the dose and duration of Inylta 5mg tablet based on the disease condition. Always take this medicine as prescribed by your doctor. The recommended starting oral dose is 5 mg twice daily. Take the tablet at the same time every day, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.


Safety Advices for Inlyta 5mg Tablet

Image Not Available  

Pregnancy

  

Inylta 5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.

Image Not Available  

Breast Feeding

  

It is unsafe to breastfeed during the treatment with Inylta 5mg tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.

Image Not Available  

Lungs

  

It is not known whether Inylta 5mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Image Not Available  

Liver

  

Before taking the Inylta 5 mg tablet, inform your doctor if you have any liver problems. It is recommended that you regularly monitor your liver function tests.

Image Not Available  

Alcohol

  

Consuming alcohol may affect the effectiveness of Inylta 5mg tablet. Stop consuming alcohol if you are taking this medicine.

Image Not Available  

Driving

  

It is unsafe to drive vehicles or operate heavy machinery after taking Inylta 5mg tablets, it may cause dizziness and impair your concentration.


Side Effects of Inlyta 5mg Tablet

The side effects of the drug range from the most common ones to those you should take a closer look at. Here is what you need to know:

 

Common

 

  • Kidney issues and dehydration
  • Sore throat and loss of appetite
  • Joint pain and weight loss
  • Skin reactions, including itching, redness, and hair loss

 

Serious

 

  • Severe fatigue and swelling
  • Chest pain or pressure, especially radiating to arms, back, neck, or jaw
  • Shortness of breath and difficulty speaking
  • Significant bleeding, such as black stools or bloody cough

Word of Advice

Inylta 5mg can cause dizziness and weakness. Avoid driving or operating heavy machinery if you experience these symptoms. Grapefruit and grapefruit juice can increase the drug's plasma concentration, which should be avoided.
 

Some formulations may contain lactose, which can cause bloating and abdominal pain in individuals with lactose intolerance. Inform your doctor if you have lactose intolerance before starting treatment. If you experience severe diarrhea, avoid high-fiber foods and drink plenty of fluids.


FAQs

Q 1. Is Inlyta 5mg tablet a chemo pill?

No, Inlyta 5mg is not a traditional chemotherapy drug; it is a targeted therapy known as a tyrosine kinase inhibitor.

Q 2. What is the success rate of Inlyta 5mg tablet?

The success rate of Inlyta can vary widely depending on several factors, such as the stage of cancer and individual patient conditions. Clinical trials have shown it to be effective in slowing disease progression and extending survival times in many patients.

Q 3. Is it safe to undergo surgery during the treatment with Inylta 5mg tablet?

Inylta 5mg tablet is associated with an increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and tell your physician before you undergo surgery or dental procedures. Your healthcare provider will suggest stopping the medication a day prior to the surgical procedure.

Q 4. Does INLYTA 5 mg tablet shrink tumors?

Yes, Inlyta 5mg can shrink tumors in some patients by inhibiting the growth of blood vessels that supply the cancer, effectively reducing its size and growth potential.

Q 5. What are all the dosage forms and strengths available for Inylta 5mg tablet?

This drug is available in the form of film-coated tablets in doses of 1mg, 3mg, 5mg, and 7mg. The usual recommended dose is 5mg twice a day.


Fact Box of Inlyta 5mg Tablet

Molecule name: Axitinib

Therapeutic class: Anticancer

Pharmacological class: tyrosine kinase inhibitors

Indications: Advanced kidney cancer


References

  1. Pfizer Labs, Electronic Medicines Compendium(EMC), [Revised on Mar 2021] [Accessed on 23rd March 2023], https://www.medicines.org.uk/emc/files/pil.4325.pdf
  2. Pfizer, Fact sheet, [Revised on Sep 2012] [Accessed on 23rd March 2023], https://cdn.pfizer.com/pfizercom/news/esmo/renal_cell_carcinoma_fact_sheet.pdf
  3. Annex I summary of Product Characteristics - European Medicines Agency. Available at:https://www.ema.europa.eu/en/documents/product-information/inlyta-epar-product-information_en.pdf (Accessed on March 25, 2023).
  4. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.

4000+ products

We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment

100% secure and trusted payment protection

Easy Return

We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.